| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CLO and Secretary
2 companies
Jennifer Daniels is CLO and Secretary at CL, with reported holdings spanning 2 companies. Jennifer Daniels's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $9.2M at current prices.
Our model assigns Jennifer Daniels a middling insider score of 57/100, based on 16 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -4.2%.
Jennifer Daniels's largest disclosed position is in CL as CLO and Secretary, worth about $8.6M. The CL filings lean toward selling, a net 408,896 shares.
Jennifer Daniels has 58 Form 4 filings on record from February 2017 to July 2026, across 2 companies: Director at Constellation Brands (STZ), 2018–2026; CLO and Secretary at Colgate-Palmolive (CL), 2017–2026.
The 91 reported transactions were 23 option or other derivative awards, 23 open-market sales, 20 option exercises and 13 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 21 sales worth about $33.9M.
The largest open-market sale was 61,633 shares of CL at an average $83.93 on February 1, 2024, about $5.2M. Twelve months later CL was up 1%.
5 of the 8 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 3 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | CL Colgate-Palmolive Company | CLO and Secretary | Sale+OE | 22,000 | $94.34 | $2,075,398.60 | -22.4% | -8.5% | - | |
| Aug 8, 2024 | CL Colgate Palmolive Co | CLO and Secretary | Sale+OE | 22,000 | $102.76 | $2,260,728.80 | -26.9% | -12.2% | -17.5% | |
| May 14, 2024 | CL Colgate Palmolive Co | CLO and Secretary | Sale+OE | 22,250 | $94.15 | $2,094,939.85 | -27.2% | +7.1% | -7.4% | |
| Feb 20, 2024 | CL Colgate Palmolive Co | CLO and Secretary | Sell10b5-1 | 9,328 | $84.23 | $785,686.52 | -13.5% | +11.6% | +3.3% | |
| Feb 1, 2024 | CL Colgate Palmolive Co | CLO and Secretary | Sale+OE10b5-1 | 61,633 | $83.93 | $5,172,697.44 | -51.5% | +6.7% | +0.7% | |
| Nov 30, 2023 | CL Colgate Palmolive Co | CLO and Secretary | Sale+OE10b5-1 | 3,800 | $79.01 | $300,219.38 | -6.1% | +10.2% | +22.7% | |
| Sep 11, 2023 | CL Colgate Palmolive Co | CLO and Secretary | Sale+OE10b5-1 | 24,704 | $73.31 | $1,811,015.65 | -31.9% | +5.0% | +44.5% | |
| May 19, 2023 | CL Colgate Palmolive Co | CLO and Secretary | Sale+OE10b5-1 | 24,703 | $79.70 | $1,968,930.38 | -31.9% | -7.4% | +17.8% | |
| Feb 17, 2023 | CL Colgate Palmolive Co | CLO and Secretary | Sell | 4,922 | $73.31 | $360,831.82 | -8.5% | +6.9% | +12.0% | |
| Aug 4, 2022 | CL Colgate Palmolive Co | CLO and Secretary | Sale+OE | 24,703 | $81.25 | $2,007,175.57 | -33.9% | -9.4% | -5.1% |